A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs
Clinical trial NCT03078478 · COMPLETED
Trial details
- NCT number
- NCT03078478
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-13
- Primary completion
- 2019-02-13
- Enrollment
- 1609
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.